Cargando…
Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction
BACKGROUND: The neutralizing antibodies (NAbs) response after COVID-19 vaccination after liver dysfunction is unclear. In this study, we evaluated the NAbs response after COVID-19 vaccination in hospitalized patients suffering from liver dysfunction. METHODS: In this cross-sectional study with longi...
Autores principales: | Li, Hu, Li, Shiyin, Xu, Pan, Wang, Xiaohao, Deng, Huan, Lei, Yu, Zhong, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889857/ https://www.ncbi.nlm.nih.gov/pubmed/36742314 http://dx.doi.org/10.3389/fimmu.2023.1084646 |
Ejemplares similares
-
Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
por: Wang, Jin, et al.
Publicado: (2021) -
Neutralizing Antibody Response in Dogs and Cats Inoculated with Commercial
Inactivated Rabies Vaccines
por: SHIRAISHI, Rikiya, et al.
Publicado: (2013) -
Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination
por: Wang, Fuzhen, et al.
Publicado: (2022) -
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
por: Ghaemi, Amir, et al.
Publicado: (2022) -
Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)